Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v7-FR | Version v2-FR | |
|---|---|---|
| Language | French | French |
| Date Updated | 2022-04-13 | 2021-12-31 |
| Drug Identification Number | 02265982 | 02265982 |
| Brand name | BLEOMYCIN FOR INJECTION | BLEOMYCIN FOR INJECTION |
| Common or Proper name | Bleomycin for Injection, 15 Units, SD Vial, 10 mL | Bleomycin for Injection, 15 Units, SD Vial, 10 mL |
| Company Name | FRESENIUS KABI CANADA LTD | FRESENIUS KABI CANADA LTD |
| Ingredients | BLEOMYCIN | BLEOMYCIN |
| Strength(s) | 15UNIT | 15UNIT |
| Dosage form(s) | POWDER FOR SOLUTION | POWDER FOR SOLUTION |
| Route of administration | SUBCUTANEOUS INTRAVENOUS INTRAPLEURAL INTRAMUSCULAR INTRAPLEURAL SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR | SUBCUTANEOUS INTRAVENOUS INTRAPLEURAL INTRAMUSCULAR INTRAPLEURAL SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR |
| Packaging size | 10 mL | 10 mL |
| ATC code | L01DC | L01DC |
| ATC description | CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES | CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES |
| Reason for shortage | Disruption of the manufacture of the drug. | Disruption of the manufacture of the drug. |
| Anticipated start date | 2022-02-02 | 2022-02-02 |
| Actual start date | ||
| Estimated end date | 2022-04-01 | 2022-03-06 |
| Actual end date | 2022-04-01 | |
| Shortage status | Resolved | Anticipated shortage |
| Tier 3 Status | No | No |
| Company comments | Fresenius Kabi Canada regrets to advise that due to a production delay, we will be encountering a supply interruption on our Bleomycin for Injection, 15 Units, SD Vial, 10 mL effective February 2, 2022 until March 6, 2022. Pfizer is an alternate supplier of Bleomycin for Injection and have been informed of our impending supply interruption. | Fresenius Kabi Canada regrets to advise that due to a production delay, we will be encountering a supply interruption on our Bleomycin for Injection, 15 Units, SD Vial, 10 mL effective February 2, 2022 until March 6, 2022. Pfizer is an alternate supplier of Bleomycin for Injection and have been informed of our impending supply interruption. |
| Health Canada comments |